Repligen Corp (RGEN)
142.43
-8.04
(-5.34%)
USD |
NASDAQ |
Nov 14, 16:00
142.17
-0.26
(-0.18%)
After-Hours: 20:00
Repligen Free Cash Flow (Quarterly): 34.79M for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 34.79M |
March 31, 2024 | 36.34M |
December 31, 2023 | 17.95M |
September 30, 2023 | 30.18M |
June 30, 2023 | 25.08M |
March 31, 2023 | 1.721M |
December 31, 2022 | 40.49M |
September 30, 2022 | -16.14M |
June 30, 2022 | 19.50M |
March 31, 2022 | -5.118M |
December 31, 2021 | 16.26M |
September 30, 2021 | 10.84M |
June 30, 2021 | 20.45M |
March 31, 2021 | 0.194M |
December 31, 2020 | 3.179M |
September 30, 2020 | 16.35M |
June 30, 2020 | 12.26M |
March 31, 2020 | 4.493M |
December 31, 2019 | 10.56M |
September 30, 2019 | 15.05M |
June 30, 2019 | 12.49M |
March 31, 2019 | 5.96M |
December 31, 2018 | 0.098M |
September 30, 2018 | 15.51M |
June 30, 2018 | 3.115M |
Date | Value |
---|---|
March 31, 2018 | 0.008M |
December 31, 2017 | 13.45M |
September 30, 2017 | -2.738M |
June 30, 2017 | 1.433M |
March 31, 2017 | -0.148M |
December 31, 2016 | 1.091M |
September 30, 2016 | -3.242M |
June 30, 2016 | 9.589M |
March 31, 2016 | -4.242M |
December 31, 2015 | 2.779M |
September 30, 2015 | 6.27M |
June 30, 2015 | 6.953M |
March 31, 2015 | -3.577M |
December 31, 2014 | -0.885M |
September 30, 2014 | 4.588M |
June 30, 2014 | 1.694M |
March 31, 2014 | 7.402M |
December 31, 2013 | 6.102M |
September 30, 2013 | 3.908M |
June 30, 2013 | 8.013M |
March 31, 2013 | 3.273M |
December 31, 2012 | 6.791M |
September 30, 2012 | 2.160M |
June 30, 2012 | 1.648M |
March 31, 2012 | 1.577M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-16.14M
Minimum
Sep 2022
40.49M
Maximum
Dec 2022
14.70M
Average
16.26M
Median
Dec 2021
Free Cash Flow (Quarterly) Benchmarks
West Pharmaceutical Services Inc | 98.80M |
QuidelOrtho Corp | 71.40M |
Perspective Therapeutics Inc | -9.917M |
Xtant Medical Holdings Inc | -5.652M |
Catheter Precision Inc | -1.742M |